TrialBlood2026

CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial.

Daniel Nunez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.